Livzon Pharmaceutical Group Inc. (1513.HK)
HKD 26.9
(-0.37%)
HKD 26.9
(-0.37%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.06 Billion CNY | 0.75% |
| 2022 | 2.04 Billion CNY | 22.97% |
| 2021 | 1.66 Billion CNY | 11.79% |
| 2020 | 1.48 Billion CNY | 27.29% |
| 2019 | 1.16 Billion CNY | 4.64% |
| 2018 | 1.11 Billion CNY | 1.3% |
| 2017 | 1.1 Billion CNY | 0.31% |
| 2016 | 1.09 Billion CNY | 11.72% |
| 2015 | 983.91 Million CNY | 16.1% |
| 2014 | 847.47 Million CNY | 32.08% |
| 2013 | 641.64 Million CNY | 17.41% |
| 2012 | 546.49 Million CNY | 28.76% |
| 2011 | 424.42 Million CNY | -5.73% |
| 2010 | 450.21 Million CNY | 32.68% |
| 2009 | 339.32 Million CNY | -1.95% |
| 2008 | 346.07 Million CNY | 6.35% |
| 2007 | 325.4 Million CNY | 15.72% |
| 2006 | 281.21 Million CNY | 17.71% |
| 2005 | 238.91 Million CNY | 12.37% |
| 2004 | 212.61 Million CNY | 13.09% |
| 2003 | 188 Million CNY | -5.69% |
| 2002 | 199.33 Million CNY | 0.89% |
| 2001 | 197.57 Million CNY | -5.51% |
| 2000 | 209.08 Million CNY | 5.28% |
| 1999 | 198.61 Million CNY | -10.14% |
| 1998 | 221.02 Million CNY | -1.27% |
| 1997 | 223.86 Million CNY | 43.03% |
| 1996 | 156.52 Million CNY | -10.8% |
| 1995 | 175.46 Million CNY | 47.58% |
| 1994 | 118.89 Million CNY | -21.13% |
| 1993 | 150.75 Million CNY | 7.72% |
| 1992 | 139.95 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.01 Billion CNY | -2.2% |
| 2024 Q3 | 1.98 Billion CNY | 0.8% |
| 2024 Q2 | 1.97 Billion CNY | -2.07% |
| 2023 Q2 | 2.25 Billion CNY | 0.9% |
| 2023 FY | 2.06 Billion CNY | 0.75% |
| 2023 Q4 | 2.06 Billion CNY | -3.82% |
| 2023 Q1 | 2.23 Billion CNY | 9.42% |
| 2023 Q3 | 2.14 Billion CNY | -5.13% |
| 2022 Q2 | 1.81 Billion CNY | 10.83% |
| 2022 Q3 | 1.81 Billion CNY | 0.13% |
| 2022 Q4 | 2.04 Billion CNY | 12.63% |
| 2022 FY | 2.04 Billion CNY | 22.97% |
| 2022 Q1 | 1.63 Billion CNY | -1.62% |
| 2021 Q4 | 1.66 Billion CNY | 14.4% |
| 2021 Q3 | 1.45 Billion CNY | -0.52% |
| 2021 FY | 1.66 Billion CNY | 11.79% |
| 2021 Q2 | 1.46 Billion CNY | 2.66% |
| 2021 Q1 | 1.42 Billion CNY | -4.32% |
| 2020 Q2 | 1.43 Billion CNY | 13.47% |
| 2020 Q1 | 1.26 Billion CNY | 8.1% |
| 2020 FY | 1.48 Billion CNY | 27.29% |
| 2020 Q3 | 1.38 Billion CNY | -3.45% |
| 2020 Q4 | 1.48 Billion CNY | 7.49% |
| 2019 FY | 1.16 Billion CNY | 4.64% |
| 2019 Q4 | 1.16 Billion CNY | 7.16% |
| 2019 Q3 | 1.09 Billion CNY | 5.22% |
| 2019 Q2 | 1.03 Billion CNY | -0.61% |
| 2019 Q1 | 1.04 Billion CNY | -6.63% |
| 2018 Q3 | 1.08 Billion CNY | -6.23% |
| 2018 Q4 | 1.11 Billion CNY | 3.19% |
| 2018 FY | 1.11 Billion CNY | 1.3% |
| 2018 Q1 | 1.17 Billion CNY | 6.36% |
| 2018 Q2 | 1.15 Billion CNY | -1.57% |
| 2017 Q2 | 1.08 Billion CNY | -3.38% |
| 2017 Q4 | 1.1 Billion CNY | -0.83% |
| 2017 Q3 | 1.11 Billion CNY | 2.19% |
| 2017 Q1 | 1.12 Billion CNY | 2.44% |
| 2017 FY | 1.1 Billion CNY | 0.31% |
| 2016 FY | 1.09 Billion CNY | 11.72% |
| 2016 Q4 | 1.09 Billion CNY | 1.0% |
| 2016 Q3 | 1.08 Billion CNY | 5.07% |
| 2016 Q2 | 1.03 Billion CNY | 1.5% |
| 2016 Q1 | 1.02 Billion CNY | 3.71% |
| 2015 Q3 | 964.75 Million CNY | 0.5% |
| 2015 FY | 983.91 Million CNY | 16.1% |
| 2015 Q1 | 925.21 Million CNY | 9.17% |
| 2015 Q2 | 959.96 Million CNY | 3.76% |
| 2015 Q4 | 983.91 Million CNY | 1.99% |
| 2014 Q3 | 863.87 Million CNY | 4.26% |
| 2014 Q1 | 739.75 Million CNY | 15.29% |
| 2014 Q2 | 828.59 Million CNY | 12.01% |
| 2014 FY | 847.47 Million CNY | 32.08% |
| 2014 Q4 | 847.47 Million CNY | -1.9% |
| 2013 Q2 | 593.45 Million CNY | 1.7% |
| 2013 FY | 641.64 Million CNY | 17.41% |
| 2013 Q4 | 641.64 Million CNY | 0.25% |
| 2013 Q1 | 583.52 Million CNY | 6.78% |
| 2013 Q3 | 640.08 Million CNY | 7.86% |
| 2012 Q4 | 546.49 Million CNY | 5.47% |
| 2012 FY | 546.49 Million CNY | 28.76% |
| 2012 Q3 | 518.13 Million CNY | 7.35% |
| 2012 Q1 | 427.28 Million CNY | 0.67% |
| 2012 Q2 | 482.65 Million CNY | 12.96% |
| 2011 FY | 424.42 Million CNY | -5.73% |
| 2011 Q4 | 424.42 Million CNY | -5.41% |
| 2011 Q3 | 448.71 Million CNY | 4.76% |
| 2011 Q2 | 428.33 Million CNY | 2.33% |
| 2011 Q1 | 418.57 Million CNY | -7.03% |
| 2010 Q1 | 421.35 Million CNY | 24.17% |
| 2010 Q4 | 450.21 Million CNY | -5.48% |
| 2010 FY | 450.21 Million CNY | 32.68% |
| 2010 Q3 | 476.31 Million CNY | 5.41% |
| 2010 Q2 | 451.87 Million CNY | 7.24% |
| 2009 Q4 | 339.32 Million CNY | 15.88% |
| 2009 Q1 | 320.3 Million CNY | -7.45% |
| 2009 Q2 | 323.22 Million CNY | 0.91% |
| 2009 Q3 | 292.83 Million CNY | -9.4% |
| 2009 FY | 339.32 Million CNY | -1.95% |
| 2008 Q1 | 304.11 Million CNY | -6.54% |
| 2008 Q2 | 319.61 Million CNY | 5.1% |
| 2008 FY | 346.07 Million CNY | 6.35% |
| 2008 Q3 | 370.46 Million CNY | 15.91% |
| 2008 Q4 | 346.07 Million CNY | -6.58% |
| 2007 Q2 | 279.17 Million CNY | -13.61% |
| 2007 Q4 | 325.4 Million CNY | 14.27% |
| 2007 FY | 325.4 Million CNY | 15.72% |
| 2007 Q1 | 323.16 Million CNY | 14.92% |
| 2007 Q3 | 284.77 Million CNY | 2.0% |
| 2006 Q3 | 272.65 Million CNY | -5.43% |
| 2006 FY | 281.21 Million CNY | 17.71% |
| 2006 Q4 | 281.21 Million CNY | 3.14% |
| 2006 Q2 | 288.3 Million CNY | 16.19% |
| 2006 Q1 | 248.12 Million CNY | 3.86% |
| 2005 Q4 | 238.91 Million CNY | 8.86% |
| 2005 Q3 | 219.46 Million CNY | -3.04% |
| 2005 Q2 | 226.34 Million CNY | 11.93% |
| 2005 Q1 | 202.21 Million CNY | -4.89% |
| 2005 FY | 238.91 Million CNY | 12.37% |
| 2004 Q4 | 212.61 Million CNY | 21.19% |
| 2004 Q3 | 175.43 Million CNY | -8.58% |
| 2004 Q2 | 191.9 Million CNY | 7.06% |
| 2004 Q1 | 179.25 Million CNY | -4.65% |
| 2004 FY | 212.61 Million CNY | 13.09% |
| 2003 Q2 | 191.04 Million CNY | -5.56% |
| 2003 Q1 | 202.3 Million CNY | 1.49% |
| 2003 FY | 188 Million CNY | -5.69% |
| 2003 Q4 | 188 Million CNY | 7.42% |
| 2003 Q3 | 175.01 Million CNY | -8.39% |
| 2002 Q3 | 231.14 Million CNY | 2.37% |
| 2002 Q1 | 219.33 Million CNY | 11.02% |
| 2002 FY | 199.33 Million CNY | 0.89% |
| 2002 Q2 | 225.78 Million CNY | 2.94% |
| 2002 Q4 | 199.33 Million CNY | -13.76% |
| 2001 Q4 | 197.57 Million CNY | 0.0% |
| 2001 Q2 | 238.47 Million CNY | 0.0% |
| 2001 FY | 197.57 Million CNY | -5.51% |
| 2000 Q4 | 209.08 Million CNY | 0.0% |
| 2000 Q2 | 289.89 Million CNY | 0.0% |
| 2000 FY | 209.08 Million CNY | 5.28% |
| 1999 FY | 198.61 Million CNY | -10.14% |
| 1999 Q2 | 243.31 Million CNY | 0.0% |
| 1999 Q4 | 198.61 Million CNY | 0.0% |
| 1998 Q4 | 221.02 Million CNY | 0.0% |
| 1998 Q2 | 194.52 Million CNY | 0.0% |
| 1998 FY | 221.02 Million CNY | -1.27% |
| 1997 Q4 | 223.86 Million CNY | 0.0% |
| 1997 FY | 223.86 Million CNY | 43.03% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 Q2 | - CNY | 0.0% |
| 1996 Q4 | 156.52 Million CNY | 0.0% |
| 1996 FY | 156.52 Million CNY | -10.8% |
| 1995 Q4 | 175.46 Million CNY | 0.0% |
| 1995 FY | 175.46 Million CNY | 47.58% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 Q4 | 118.89 Million CNY | 0.0% |
| 1994 Q2 | - CNY | 0.0% |
| 1994 FY | 118.89 Million CNY | -21.13% |
| 1993 FY | 150.75 Million CNY | 7.72% |
| 1992 FY | 139.95 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -16794.739% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | -48.393% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -28264.091% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -568.83% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | -377.239% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -591.248% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -3180.147% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -1997.013% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -1073.512% |
| SSY Group Limited | 1.08 Billion HKD | -89.698% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -2149.988% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -548.295% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 94.128% |